Compare DNA & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DNA | BVS |
|---|---|---|
| Founded | 2008 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 562.3M | 508.4M |
| IPO Year | N/A | 2021 |
| Metric | DNA | BVS |
|---|---|---|
| Price | $9.20 | $7.09 |
| Analyst Decision | Strong Sell | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $9.00 | ★ $13.33 |
| AVG Volume (30 Days) | ★ 1.2M | 321.3K |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.15 |
| Revenue | $180,606,000.00 | ★ $563,829,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.28 | $7.11 |
| P/E Ratio | ★ N/A | $46.17 |
| Revenue Growth | N/A | ★ 1.58 |
| 52 Week Low | $5.00 | $5.81 |
| 52 Week High | $17.58 | $11.89 |
| Indicator | DNA | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 45.00 | 45.51 |
| Support Level | $8.56 | $7.39 |
| Resistance Level | $9.38 | $7.66 |
| Average True Range (ATR) | 0.55 | 0.39 |
| MACD | 0.26 | -0.01 |
| Stochastic Oscillator | 69.31 | 45.49 |
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.